Esophageal Diseases  >>  gemcitabine  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gemcitabine / Generic mfg.
NCT00019513: Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Completed
1
108
US
fluorouracil, gemcitabine hydrochloride, leucovorin calcium
National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI)
Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer, Lung Cancer, Lymphoma, Pancreatic Cancer, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific
 
06/04
NCT00014456: Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Completed
1
35
US
filgrastim, docetaxel, gemcitabine hydrochloride
Dartmouth-Hitchcock Medical Center, National Cancer Institute (NCI)
Bladder Cancer, Breast Cancer, Carcinoma of Unknown Primary, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Melanoma (Skin), Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Sarcoma
10/05
10/05
NCT00101907: Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer

Terminated
1
41
US
AMG 706, Panitumumab, Vectibix, Gemcitabine, Gemzar, Cisplatin, cisplatinum, cis-diamminedichloridoplatinum(II) (CDDP)
Amgen
Lung Cancer, Pancreatic Cancer, Esophageal Cancer
06/07
04/08

Download Options